An international phase 3 clinical trial that treated patients with high-risk localized and locally advanced prostate cancer ...
An international phase 3 clinical trial that treated patients with high-risk localized and locally advanced prostate cancer ...
A phase 3 PROTEUS substudy published in European Urology reports that perioperative apalutamide plus hormone therapy around ...
An international phase 3 clinical trial that treated patients with high-risk localized and locally advanced prostate cancer ...
Add Yahoo as a preferred source to see more of our stories on Google. Getting your prostate removed can seem daunting, and recovery can involve coping with some temporary but significant changes to ...
The multicenter StereoBed trial will randomize 284 patients to compare five-fraction stereotactic radiotherapy with standard ...
New substudy results showed a 51% lower estimated risk of metastasis or death over time with perioperative apalutamide plus ...
The NeuroSAFE technique significantly improves erectile function outcomes post-prostatectomy, nearly doubling the number of patients with no or mild erectile dysfunction. Intraoperative tissue ...
Getting your prostate removed can seem daunting, and recovery can involve coping with some temporary but significant changes to your urinary, sexual, and mental health. However, the five-year survival ...
Johnson & Johnson (NYSE: JNJ) today announced new results from the Phase 3 PROTEUS substudy that directly compared the investigational use of apalutamide plus androgen deprivation therapy (ADT), given ...